Abstract
Previous studies established some Ti compounds as having marked activity against tumors of the
gastrointestinal tract and lack of side effects common to widely used cytostatic agents. We describe pertinent
structural features of known antitumor Ti agents and other potentially active compounds. Particularly
noteworthy features are that